Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats

European Journal of Pharmacology

Volumn 701, Issue 1-3, 2013, Pages 176-180

  Biezonski, Dominik K ^a,d   Piper, Brian J ^a,c   Shinday, Nina M ^a   Kim, Peter J ^a,e   Ali, Syed F ^b   Meyer, Jerrold S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c HUSSON UNIVERSITY   (United States)

^d Husson University ^*  (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

3,4 methylenedioxymethamphetamine; Dihydroxyphenylacetic acid; Dopamine transporter; Homovanillic acid; Neurotoxicity; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; SEROTONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; FRONTAL CORTEX; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HYDROXYINDOLEACETIC ACID; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TIME FACTORS;

EID: 84873711432     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.12.024     Document Type: Article

References (42)

1. J.A. Able, G.A. Gudelsky, C.V. Vorhees, and M.T. Williams 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory Biol. Psychiatry 59 2006 1219 1226
2. S.F. Ali, G.D. Newport, R.R. Holson, W. Slikker, and J.F. Bowyer Low environmental temperature or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice Brain Res. 658 1994 33 38
3. 3H]paroxetine-labeled serotonin uptake sites J. Pharmacol. Exp. Ther. 242 1987 911 916
4. D.K. Biezonski, and J.S. Meyer Effects of 3,4- methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity J. Neurochem. 112 2010 951 962
5. M.I. Colado, E. O'Shea, and A.R. Green Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function Psychopharmacology 173 2004 249 263
6. J.C. Cole, and H.R. Sumnall The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) Neurosci. Biobehav. Rev. 27 2003 199 217
7. D.L. Commins, G. Vosmer, R.M. Virus, W.L. Woolverton, C.R. Schuster, and L.S. Seiden Biochemical and histological evidence that methylenedioxymethamphetamine is toxic to neurons in the rat brain J. Pharmacol. Exp. Ther. 241 1987 338 345
8. E. Daniela, K. Brennan, D. Gittings, L. Hely, and S. Schenk Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats Pharmacol. Biochem. Behav. 77 2004 745 750
9. R. de la Torre, and M. Farré Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans Trends Pharmacol. Sci. 25 2004 505 508
10. I. Elayan, J.W. Gibb, G.R. Hanson, R.L. Foltz, H.K. Lim, and M. Johnson Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5- methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine Eur. J. Pharmacol. 221 1992 281 288
11. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) Pharmacol. Rev. 55 2003 463 508
12. A.R. Green, E. O'Shea, and M.I. Colado A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response Eur. J. Pharmacol. 500 2004 3 13
13. J.P. Hansen, E.L. Riddle, V. Sandoval, J.M. Brown, J.W. Gibb, G.R. Hanson, and A.E. Fleckenstein Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity J. Pharmacol. Exp. Ther. 300 2002 1093 1100
14. D.C. Jones, C. Duvauchelle, A. Ikegami, C.M. Olsen, S.S. Lau, R. de la Torre, and T.J. Monks Serotonergic neurotoxic metabolites of ecstasy identified in rat brain J. Pharmacol. Exp. Ther. 313 2005 422 431
15. A.D. Kalechstein, R. De La Garza, J.J. Mahoney, W.E. Fantegrossi, and T.F. Newton MDMA use and neurocognition: a meta-analytic review Psychopharmacology 189 2007 531 537
16. S.J. Kish, Y. Furukawa, L. Ang, S.P. Vorce, and K.S. Kalasinsky Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user Neurology 55 2000 294 296
17. R. Lew, K.E. Sabol, C. Chou, G.L. Vosmer, J. Richards, and L.S. Seiden Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: radioligand binding and autoradiography studies J. Pharmacol. Exp. Ther. 276 1996 855 865
18. L. Lyles, and J.L. Cadet Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms Brain Res. Rev. 42 2003 155 168
19. A. Mayerhofer, K.A. Kovar, and W.J. Schmidt Changes in serotonin, dopamine and noradrenalin levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats Neurosci. Lett. 308 2001 99 102
20. U.D. McCann, A. Ridenour, Y. Shaham, and G.A. Ricaurte Serotonin neurotoxicity after (±) 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy): a controlled study in humans Neuropsychopharmacology 10 1994 129 138
21. U.D. McCann, V. Eligulashvili, and G.A. Ricaurte (±)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies Neuropsychobiology 42 2000 11 16
22. U.D. McCann, Z. Szabo, M. Vranesic, M. Palermo, W.B. Mathews, H.T. Ravert, R.F. Dannals, and G.A. Ricaurte Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4- methylenedioxymethamphetamine (ecstasy) users: relationship to cognitive performance Psychopharmacology 200 2008 439 450
23. I.S. McGregor, C.G. Gurtman, K.C. Morley, K.J. Clemens, A. Blokland, K.M. Li, J.L. Cornish, and G.E. Hunt Increased anxiety and depressive symptoms months after MDMA (Ecstasy) in rats: drug-induced hyperthermia does not predict long-term outcomes Psychopharmacology 168 2003 465 474
24. K.C. Morley, J.E. Gallate, G.E. Hunt, P.E. Mallet, and I.S. McGregor Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (ecstasy) Eur. J. Pharmacol. 433 2001 91 99
25. M.J. Nirenberg, J. Chan, Y. Liu, R.H. Edwards, and V.M. Pickel Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals Synapse 26 1997 194 198
26. E. O'Hearn, G. Battaglia, E.B. De Souza, M.J. Kuhar, and M.E. Molliver Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity J. Neurosci. 8 1988 2788 2803
27. A.C. Parrott Chronic tolerance to recreational MDMA (3.4, methylenedioxymethamphetamine) or Ecstasy J. Psychopharmacol. 19 2005 71 83
28. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego, CA
29. B.J. Piper A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) Neurotoxicol. Teratol. 29 2007 288 300
30. B.J. Piper, S.F. Ali, L.D. Daniels, and J. Meyer Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats Synapse 64 2010 421 431
31. B.J. Piper, J.B. Fraiman, and J.S. Meyer Repeated MDMA (Ecstasy) exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding Dev. Psychobiol. 47 2005 145 157
32. B.J. Piper, J.B. Fraiman, C.B. Owens, S.F. Ali, and J.S. Meyer Dissociation of the neurochemical and behavioral consequences of MDMA (Ecstasy) by citalopram Neuropsychopharmacology 33 2007 1192 1205
33. G.A. Ricaurte, L.S. Forno, M.A. Wilson, L.E. DeLanney, I. Irwin, M.E. Molliver, and J.W. Langston (±)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates J. Am. Med. Assoc. 260 1988 51 55
34. G.A. Ricaurte, and U.D. McCann Neurotoxic amphetamine analogues: effects in monkeys and implications for humans Ann. N.Y. Acad. Sci. 648 1992 371 382
35. G.A. Ricaurte, J. Yuan, G. Hatzidimitriou, B.J. Cord, and U.D. McCann Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (ecstasy) Science 297 2002 2260 2263
36. G.A. Ricaurte, J. Yuan, and U.D. McCann (±)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals Neuropsychobiology 42 2000 5 10
37. T.W. Robbins, and A.C. Roberts Differential regulation of fronto-executive function by the monoamines and acetylcholine Cereb. Cortex 17 2007 151 160
38. K.E. Sabol, R. Lew, J.B. Richards, G.L. Vosmer, and L.S. Seiden Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: synaptosomal uptake and tissue concentrations J. Pharmacol. Exp. Ther. 276 1996 846 854
39. V. Sanchez, E. O'shea, K.S. Saadat, J.M. Elliott, M.I. Colado, and A.R. Green Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurons J. Psychopharmacol. 18 2004 412 416
40. C.J. Schmidt, and J.H. Kehne Neurotoxicity of MDMA: neurochemical effects Ann. N.Y. Acad. Sci. 600 1990 665 680
41. 18F-dopa PET study Neuropsychopharmacology 36 2011 735-743
42. T. Xie, L. Tong, M.W. McLane, G. Hatzidimitriou, J. Yuan, U. McCann, and G. Ricaurte Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines Neuropsychopharmacology 31 2006 2639 2651